Find Grants for Higher Education
Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.
Add Your Heading Text Here
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Deadline: November 16, 2027
Opportunity Number: PAR-25-266
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.865
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-269
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-270
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-183
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-285
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-177
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-181
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-178
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-179
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-182
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-180
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-184
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
Deadline: May 7, 2027
Opportunity Number: PAR-25-272
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.866, 93.396, 93.865
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-288
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-159
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.273
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
Deadline: May 7, 2027
Opportunity Number: PAR-25-279
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.396, 93.866, 93.865, 93.286
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-289
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-292
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.866, 93.361, 93.393, 93.307, 93.399, 93.396, 93.279, 93.242
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
Deadline: November 17, 2026
Opportunity Number: PAR-25-158
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.273
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-281
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242, 93.313
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
Deadline: December 23, 2027
Opportunity Number: RFA-HL-26-019
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: December 23, 2027
Status: Posted
CFDA Numbers: 93.837, 93.233, 93.839, 93.838
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-291
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-282
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242, 93.313
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-290
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
Deadline: December 23, 2027
Opportunity Number: RFA-HL-26-020
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: December 23, 2027
Status: Posted
CFDA Numbers: 93.839, 93.233, 93.837, 93.838